...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >External Application of Traditional Chinese Medicine for Venous Ulcers: A Systematic Review and Meta-Analysis
【24h】

External Application of Traditional Chinese Medicine for Venous Ulcers: A Systematic Review and Meta-Analysis

机译:中医在静脉溃疡中的外部应用:系统评价和荟萃分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective. To evaluate the effectiveness of external application of traditional Chinese medicine (EA-TCM) on venous ulcers.Methods. Seven databases were searched until April 2015 for randomized controlled trials (RCTs) of EA-TCM for venous ulcers. Risk of bias was assessed using Cochrane Handbook guidelines. Study outcomes were presented as risk ratios (RRs) for dichotomous data or mean differences (MDs) for continuous data.Results. Sixteen of 193 potentially relevant trials met the inclusion criteria; however, their methodological qualities were low. Comparison of the same intervention strategies revealed significant differences in total effectiveness rates between EA-TCM and conventional therapy groups (RR = 1.22, 95% confidence interval [CI] = 1.16–1.29, andP<0.00001). Compared to conventional therapy, EA-TCM combined with conventional therapy had a superior total effectiveness rate (RR = 1.11, 95% CI = 1.04–1.19, andP=0.003). There were no significant differences in recurrence rates during followup and final pain measurements between the experimental and those in the control groups (RR = 0.86, 95% CI = 0.31–2.39, andP=0.85; MD −0.75, 95% CI = −2.15–0.65, andP=0.29).Conclusion. The evidence that EA-TCM is an effective treatment for venous ulcers is encouraging, but not conclusive due to the low methodological quality of the RCTs. Therefore, more high-quality RCTs with larger sample sizes are required.
机译:目的。评估中药外用剂对静脉溃疡的疗效。直到2015年4月,已对七个数据库进行了搜索,以了解EA-TCM对静脉溃疡的随机对照试验(RCT)。使用Cochrane手册指南评估了偏倚风险。研究结果以二分数据的风险比(RRs)或连续数据的均数差(MDs)表示。 193个潜在相关的试验中有16个符合纳入标准;但是,他们的方法学素质很低。相同干预策略的比较显示,EA-TCM与常规治疗组的总有效率存在显着差异(RR = 1.22,95%置信区间[CI] = 1.16–1.29,P <0.00001)。与常规疗法相比,EA-TCM与常规疗法相结合具有更高的总有效率(RR = 1.11,95%CI = 1.04-1.19,P = 0.003)。实验组和对照组之间在随访和最终疼痛测量期间的复发率无显着差异(RR = 0.86,95%CI = 0.31–2.39,P = 0.85; MD -0.75,95%CI = -2.15 –0.65,P = 0.29)。结论。 EA-TCM是一种有效治疗静脉溃疡的证据令人鼓舞,但由于RCT的方法学质量较差,因此尚无定论。因此,需要更多具有更大样本量的高质量RCT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号